Clinical trialNCT06714591RecruitingPhase 1Interventional

Evaluate the Safety, Tolerability, Pharmacokinetic Profile, Efficacy of Bl-M11D1

SponsorSystImmune Inc.Enrollment120Relapsed/Refractory Acute Myeloid Leukemia

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Olu Lawson
SystImmune Inc.
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

18 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

City of Hope
Duarte, California, United States
Anthony Stein, MD
Recruiting
Ucla Ronald Reagan Medical Center
Los Angeles, California, United States
Gary Schiller, MD
Recruiting
University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States
Christine McMahon
Recruiting
Yale Cancer Center, Smilow Cancer Hospital at Yale New Haven
New Haven, Connecticut, United States
Amer Zeidan, MD
Recruiting
Moffitt Cancer Center
Tampa, Florida, United States
David Sallman, MD
Recruiting
Northwestern Memorial Hospital
Chicago, Illinois, United States
Jessica Altman →
Recruiting
the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Baltimore, Maryland, United States
Ivana Gojo
Recruiting
Start Midwest/the Cancer and Hematology Center
Grand Rapids, Michigan, United States
Andrew Sochacki, MD
Recruiting
John Theurer Cancer Center-Hackensack
Hackensack, New Jersey, United States
James McCloskey
Recruiting
Oncology Hematology Care Clinical Trials, Llc
Cincinnati, Ohio, United States
Kruti Patel, MD
Recruiting
the Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
Uma Borate, MD
Recruiting
Wvci Oncology Associates of Oregon
Eugene, Oregon, United States
Luke Fletcher, MD
Recruiting
Oregon Health and Science University
Portland, Oregon, United States
Curtis Lachowiez
Recruiting
Temple Health Fox Chase Cancer Center
Philadelphia, Pennsylvania, United States
Sasha A Vartanov
Recruiting
Scri -Tristar Bmt
Nashville, Tennessee, United States
Stephen Strickland, MD
Recruiting
Md Anderson Cancer Center
Houston, Texas, United States
Courtney DiNardo, MD
Recruiting
Virginia Cancer Specialists
Fairfax, Virginia, United States
Mitul Gandhi, MD
Recruiting
Fred Hutchinson Cancer Center
Seattle, Washington, United States
Mary Elizabeth Percival, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

BL-M11D1 →

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 19 Dec 2024
Primary completion: 31 Dec 2026
Completion: 30 Mar 2027
Last update posted: 25 Jun 2026
Registered enrollment: 120
Registry id: NCT06714591

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.